1 / 16

Real-World Safety and Effectiveness of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: German Registry Data

This study examines the safety, effectiveness, and patient-reported outcomes of Glecaprevir/Pibrentasvir treatment in patients with chronic Hepatitis C virus infection using data from the German Hepatitis C Registry.

njacqueline
Download Presentation

Real-World Safety and Effectiveness of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: German Registry Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. REAL-WORLD SAFETY, EFFECTIVENESS, AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR: DATA FROM THE GERMAN HEPATITIS C-REGISTRY

  2. Disclosures

  3. Disclosures

  4. German Hepatitis C-Registry (DHC‐R)

  5. Background and Objective

  6. Study Population Receiving On-Label Glecaprevir/Pibrentasvir

  7. Demographics and Clinical Characteristics at Baseline

  8. Demographics and Clinical Characteristics at Baseline

  9. SVR12 Rates in the Effectiveness Population

  10. SVR12 Rates in the Effectiveness Population

  11. SVR12 Rates in HCV Treatment-Naïve Non-Cirrhotic Patients

  12. SF-36 Component Summary Scores at Baseline

  13. SF-36 Physical Component Summary Score

  14. SF-36 Mental Component Summary Score

  15. Safety

  16. Summary

More Related